title: The mode and tempo of hepatitis C virus evolution within and among hosts.
abstract: BACKGROUND
  Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infections in humans. Despite the virus' public health importance and a wealth of sequence data, basic aspects of HCV molecular evolution remain poorly understood. Here we investigate three sets of whole HCV genomes in order to directly compare the evolution of whole HCV genomes at different biological levels: within- and among-hosts. We use a powerful Bayesian inference framework that incorporates both among-lineage rate heterogeneity and phylogenetic uncertainty into estimates of evolutionary parameters.
  
  
  RESULTS
  Most of the HCV genome evolves at ~0.001 substitutions/site/year, a rate typical of RNA viruses. The antigenically-important E1/E2 genome region evolves particularly quickly, with correspondingly high rates of positive selection, as inferred using two related measures. Crucially, in this region an exceptionally higher rate was observed for within-host evolution compared to among-host evolution. Conversely, higher rates of evolution were seen among-hosts for functionally relevant parts of the NS5A gene. There was also evidence for slightly higher evolutionary rate for HCV subtype 1a compared to subtype 1b.
  
  
  CONCLUSIONS
  Using new statistical methods and comparable whole genome datasets we have quantified, for the first time, the variation in HCV evolutionary dynamics at different scales of organisation. This confirms that differences in molecular evolution between biological scales are not restricted to HIV and may represent a common feature of chronic RNA viral infection. We conclude that the elevated rate observed in the E1/E2 region during within-host evolution more likely results from the reversion of host-specific adaptations (resulting in slower long-term among-host evolution) than from the preferential transmission of slowly-evolving lineages.
authors: Department of Zoology, Oxford University, South Parks Road, UK.
authors: Rebecca R
authors: RR
authors: Gray
authors: Joe
authors: J
authors: Parker
authors: Philippe
authors: P
authors: Lemey
authors: Marco
authors: M
authors: Salemi
authors: Aris
authors: A
authors: Katzourakis
authors: Oliver G
authors: OG
authors: Pybus
references: Lancet. 1995 Aug 5;346(8971):372-3
references: 7677904
references: J Exp Med. 2005 Jun 6;201(11):1741-52
references: 15939790
references: Virology. 1992 Oct;190(2):894-9
references: 1325713
references: Hepatology. 1998 Jan;27(1):223-7
references: 9425941
references: FEMS Immunol Med Microbiol. 2003 Nov 28;39(2):125-32
references: 14625095
references: J Virol. 2000 Mar;74(6):2541-9
references: 10684268
references: J Mol Evol. 1997 Sep;45(3):238-46
references: 9302317
references: J Gen Virol. 2005 Jan;86(Pt 1):115-120
references: 15604437
references: J Med Virol. 2008 Feb;80(2):247-53
references: 18098147
references: Nat Rev Genet. 2009 Aug;10(8):540-50
references: 19564871
references: J Exp Med. 2005 Jun 6;201(11):1725-31
references: 15939788
references: RNA. 2002 Jun;8(6):824-41
references: 12088154
references: J Gen Virol. 2003 Feb;84(Pt 2):441-446
references: 12560577
references: Mol Biol Evol. 2006 Jan;23(1):7-9
references: 16177232
references: J Virol. 1999 Apr;73(4):2938-46
references: 10074143
references: J Virol. 2006 Feb;80(4):1637-44
references: 16439520
references: Oncogene. 2006 Jun 26;25(27):3834-47
references: 16799625
references: J Gen Virol. 1992 Oct;73 ( Pt 10):2725-9
references: 1383400
references: Science. 2001 Jun 22;292(5525):2323-5
references: 11423661
references: PLoS Biol. 2006 May;4(5):e88
references: 16683862
references: AIDS Rev. 2006 Jul-Sep;8(3):125-40
references: 17078483
references: Science. 2010 Sep 17;329(5998):1487
references: 20847261
references: J Mol Evol. 1994 Jan;38(1):50-6
references: 8151715
references: J Mol Evol. 2002 Jan;54(1):62-70
references: 11734899
references: Mol Biol Evol. 2007 Aug;24(8):1586-91
references: 17483113
references: J Clin Invest. 1995 Jul;96(1):224-30
references: 7542279
references: Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3392-6
references: 1849654
references: Science. 2004 Jan 16;303(5656):327-32
references: 14726583
references: J Viral Hepat. 2005 Nov;12(6):594-603
references: 16255760
references: BMC Evol Biol. 2007 Nov 08;7:214
references: 17996036
references: J Virol. 1990 Feb;64(2):864-72
references: 2296085
references: J Exp Med. 2004 Dec 20;200(12):1593-604
references: 15611288
references: Intervirology. 2012;55(1):1-11
references: 21293098
references: J Virol. 2000 Oct;74(19):9028-38
references: 10982347
references: J Hepatol. 2004 May;40(5):831-6
references: 15094232
references: Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13253-8
references: 10557307
references: Nat Rev Microbiol. 2007 Jun;5(6):453-63
references: 17487147
references: J Gen Virol. 1999 Apr;80 ( Pt 4):879-886
references: 10211956
references: Mol Biol Evol. 2001 Jun;18(6):1001-13
references: 11371589
references: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15584-9
references: 12438687
references: J Mol Evol. 2002 Feb;54(2):156-65
references: 11821909
references: J Infect Dis. 2004 Jun 1;189(11):2037-46
references: 15143471
references: J Exp Med. 2005 Jun 6;201(11):1753-9
references: 15939791
references: Antimicrob Agents Chemother. 2010 Sep;54(9):3641-50
references: 20585111
references: J Virol. 2005 Jul;79(13):8217-29
references: 15956567
references: PLoS Med. 2009 Dec;6(12):e1000198
references: 20041120
references: Hepatology. 2008 Jul;48(1):38-47
references: 18537193
references: Science. 2000 Apr 14;288(5464):339-44
references: 10764648
references: J Virol. 2009 Jan;83(2):1071-82
references: 18971279
references: J Virol. 2004 Apr;78(7):3447-54
references: 15016867
references: J Virol. 1998 Jun;72(6):4893-905
references: 9573256
references: J Viral Hepat. 1999 Jul;6 Suppl 1:47-8
references: 10760035